Intertek’s Pharmaceutical Audit Services Team celebrates 15 years of excellence
Celebrating 15 years of delivering flexible
auditing solutions for the global healthcare, pharmaceutical, and cosmetics
sectors, our Pharmaceutical Audit Services Team have continually innovated to build a set of relevant auditing services to help clients meet the evolving challenges of driving quality and
visibility across complex global supply chains.
Intertek, a leading Total Quality Assurance provider to industries worldwide, is celebrating 15 years of delivering flexible auditing solutions for the global healthcare, pharmaceutical, and cosmetics sectors.
The management of suppliers and subcontractors is a critical part of quality management systems. The control and the evaluation of suppliers or subcontractors through robust auditing programmes is key to confirming that a supplier has an acceptable level of compliance against industry standards.
Since its launch 15 years ago, the auditing team has provided audits for the pharmaceutical, cosmetics, and medical device industries. The team introduced an innovative online audit platform in 2009 which allows secure and confidential access to a real-time view of scheduled supplier audits (shared or individual), enabling optimisation of global audit programmes.
With continual innovation over the years, the team have built a flexible set of audit solutions that help clients meet the evolving challenges of driving quality and visibility across supply chains. Innovations include internal audit support, existing audit reports purchase, CAPA evaluation and follow-up support. Over the last 20 months, Intertek’s remote auditing solution was enhanced and became an alternative to in-person audits which became more difficult due to the challenges caused by COVID-19. Since the launch of this team, a multitude of clients around the globe have trusted Intertek to schedule and deliver thousands of audits and approved audit reports.
Ross McCluskey, EVP Europe & Central Asia, said: “With over 1600 global clients who put their trust in us, we are delighted to celebrate 15 years of delivering auditing excellence. We would like to thank everyone who has contributed to our journey, and we look forward to continuing to work with our clients and providing them with our world class auditing capabilities in the future.”
Soria Catherine, Head of Audits Activity said: “Across our 15 years of auditing experience, we have continually innovated to provide a flexible set of cost-effective and responsive auditing solutions for the global pharmaceutical and healthcare industries. Our team of experienced auditors has in-depth technical knowledge of industry quality best practices and the organisational competence to help clients drive quality across these complex healthcare product supply chains.”
The Intertek auditing team for the healthcare industries conducts audits all around the world and serves the global pharmaceutical, medical device, consumer healthcare, and cosmetics industries.
Related News
-
News How to disrupt an industry as big as pharma for the better?
In this interview, hear from Matthew Wise, Head of Data at CCD Partners, on the companies they've been looking into that are offering new and interesting perspectives that have the potential to shake up the pharmaceutical industry, and how they'... -
News CPHI Pharma Awards 2024: Meet the winners from the CPHI Celebration
This year we had a lot to celebrate, the 35th Anniversary of CPHI, and our esteemed award winners, of which we included two additional categories this year, the Future Leader award, and Woman of the Year award. -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
News A Day in the Life of a Global CDMO Chapter Lead – Manufacturing
The 'Day in the Life of' series has covered many aspects of the pharmaceutical pipeline, including R&D and procurement, now we're taking a look at manufacturing from a global CDMO perspective. -
News Eisai Alzheimer’s drug authorised in UK but still faces obstacles
In partnership with BioArctic AB, pharmaceutical company Eisai has been granted Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for its Alzheimer’s disease drug product Leqembi. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance